banner
Inquiry

Cat. No.: X24-11-LY178

2-(2-Thiazolylazo)-p-cresol

Synonym: 1823-44-5; 4-Methyl-2-(1,3-thiazol-2-yldiazenyl)phenol; (E)-4-Methyl-2-(thiazol-2-yldiazenyl)phenol; 2-(Thiazolylazo)-p-cresol; Phenol, 4-methyl-2-(2-thiazolylazo)-; 6(E)-4-Methyl-6-(2-thiazolylhydrazinylidene)-1-cyclohexa-2,4-dienone; 6(E)-4-Methyl-6-(1,3-thiazol-2-ylhydrazinylidene)cyclohexa-2,4-dien-1-one

  • MDL: MFCD00005323
  • CAS Number: 1823-44-5
  • Compound CID: 137226
img
Product Size
5 mg; 10 mg; 25 mg; 100 mg; 1 g
Price
Datasheet
MSDS
Properties
Description
2-(2-Thiazolylazo)-p-cresol is an organic combination contains a thiazole ring and a coupled phenolic structure.
Molecular Weight
219.26
Molecular Formula
C10H9N3OClFS
Flash
191.2°C
Form
Powder
Purity
≥96%, determined by HPLC.
Solubility
50 mg/mL, ethanol:CHCl3 (1:1) clear, red to brown solution.
Identity
Confirmed by FT-IR.
Boiling Point
392.6°C
Applications
2-(2-Thiazolylazo)-p-cresol is often used as ligands or reagents.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.
0